By Iain Gilbert
Date: Tuesday 26 Aug 2025
(Sharecast News) - Diagnostics business EKF Diagnostics said on Tuesday that it has signed three new contracts in its key organic growth area of Hematology point-of-care testing, worth approximately €4.65m.
Holding(s) in Company | 19-Sep-2025 | 16:25 | RNS |
Long Term Incentive Plan | 16-Sep-2025 | 07:15 | RNS |
Half-year Report | 16-Sep-2025 | 07:00 | RNS |
Notice of interim results | 10-Sep-2025 | 07:00 | RNS |
Hematology contracts signed worth EUR 4.65m | 26-Aug-2025 | 07:00 | RNS |
Database | 28-Oct-2006 | Telegraph |
Pollster gets the vote | 22-Jan-2006 | Scotland on Sunday |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 31.00p |
Change Today | 0.90p |
% Change | 2.99 % |
52 Week High | 31.90 |
52 Week Low | 18.75 |
Volume | 47,018 |
Shares Issued | 449.09m |
Market Cap | £139.22m |
Beta | 0.00 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 02-Nov-23 | 03-Nov-22 |
Paid | 01-Dec-23 | 01-Dec-22 |
Amount | 1.20p | 1.20p |
Time | Volume / Share Price |
15:39 | 16,464 @ 30.37p |
15:29 | 3,947 @ 30.40p |
15:29 | 189 @ 30.40p |
15:29 | 1,550 @ 30.40p |
15:29 | 2,500 @ 30.40p |
CFO | Stephen (Steve) Young |
CEO | Gavin T Jones |
You are here: research